New Hypnotic Drug Development and Pharmacologic Considerations for Clinical Anesthesia
Mariah Kincaid Tanious1, Sascha S Beutler1, Alan D Kaye2
1Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
Researchers are reviewing new anesthetic induction agents, focusing on rapid onset, safety, and predictable clearance. This update covers promising drugs for clinical practice, healthcare costs, and perioperative care.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- The quest for ideal anesthetics began with ether's public demonstration in 1846.
- Ideal anesthetics require rapid onset, potent sedation-hypnosis, a high therapeutic ratio, predictable metabolism, and minimal side effects.
Purpose of the Study:
- To review progress in novel anesthetic induction agent development.
- To update on promising drugs nearing clinical practice.
- To discuss trends, healthcare costs, and perioperative implications of new agents.
Main Methods:
- Literature review of current anesthetic induction agent development.
- Analysis of promising drug candidates for clinical practice.
- Examination of trends in anesthetic development and their implications.
Main Results:
- Identification of key characteristics of ideal anesthetics.
- Overview of novel induction agents under development.
- Discussion of economic and perioperative impacts.
Conclusions:
- The field continues to evolve, seeking improved anesthetic agents.
- New drugs show promise for enhancing patient care and safety.
- Development trends impact healthcare economics and surgical outcomes.
More Related Videos
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
08:16Optogenetic Activation of Afferent Pathways in Brain Slices and Modulation of Responses by Volatile Anesthetics
Published on: July 23, 2020
Related Concept Videos
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
